SCHEMBL14720731

SCHEMBL14720731

O=S(=O)(NC1CCOCC1)c1ccc(C=C2CCN(C3CCC3)CC2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.45
KCNH2 Q12809 1/20 0.43
HRH3 Q9Y5N1 1/20 0.43
SMN1; SMN2 Q16637 5/20 0.43
KDM4E B2RXH2 1/20 0.43
RECQL P46063 1/20 0.43
LMNA P02545 5/20 0.41
HPGD P15428 2/20 0.41
CRHBP P24387 1/20 0.40
CRHR2 Q13324 1/20 0.40
MCOLN3 Q8TDD5 1/20 0.40
PKM P14618 2/20 0.38
HTT P42858 5/20 0.38
TSHR P16473 4/20 0.38
CYP3A4 P08684 1/20 0.38
MAPK1 P28482 1/20 0.38
GAA P10253 3/20 0.37
MAPT P10636 1/20 0.37
HCRTR1 O43613 1/20 0.37
MEN1 O00255 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14720786 0.84 DRD2 (0.38) ALDH1A1KCNH2HRH3LMNAHPGD
SCHEMBL14720486 0.83 NAMPT (0.38) ALDH1A1HRH3SMN1; SMN2KDM4EHPGD
SCHEMBL14721060 0.81 KCNH2 (0.43) ALDH1A1KCNH2HRH3SMN1; SMN2KDM4E
SCHEMBL14720887 0.81 POLB (0.52) ALDH1A1SMN1; SMN2KDM4ELMNAHPGD
SCHEMBL14720144 0.78 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2KDM4ELMNAHTT
SCHEMBL14720412 0.74 NAMPT (0.44) HRH3SMN1; SMN2KDM4EGAAKMT2A
SCHEMBL14721402 0.73 MAPT (0.44) ALDH1A1HRH3SMN1; SMN2LMNAHPGD
SCHEMBL14720817 0.72 SRD5A2 (0.43) ALDH1A1HRH3KDM4ELMNAMEN1
SCHEMBL14722546 0.72 USP2 (0.45) HRH3HPGD
SCHEMBL14720831 0.71 HRH3 (0.42) HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO claimed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed